Chemical or traumatic damage to the liver is frequently associated with aberrant healing (fibrosis) that overrides liver regeneration 1-5 . The mechanism by which hepatic niche cells differentially modulate regeneration and fibrosis during liver repair remains to be defined [6] [7] [8] . Hepatic vascular niche predominantly represented by liver sinusoidal endothelial cells deploys paracrine trophogens, known as angiocrine factors, to stimulate regeneration 9-15 . Nevertheless, it is not known how pro-regenerative angiocrine signals from liver sinusoidal endothelial cells is subverted to promote fibrosis 16, 17 . Here, by combining an inducible endothelial-cell-specific mouse gene deletion strategy and complementary models of acute and chronic liver injury, we show that divergent angiocrine signals from liver sinusoidal endothelial cells stimulate regeneration after immediate injury and provoke fibrosis after chronic insult. The pro-fibrotic transition of vascular niche results from differential expression of stromalderived factor-1 receptors, CXCR7 and CXCR4 (refs 18-21), in liver sinusoidal endothelial cells. After acute injury, CXCR7 upregulation in liver sinusoidal endothelial cells acts with CXCR4 to induce transcription factor Id1, deploying pro-regenerative angiocrine factors and triggering regeneration. Inducible deletion of Cxcr7 in sinusoidal endothelial cells (Cxcr7 iDEC/iDEC ) from the adult mouse liver impaired liver regeneration by diminishing Id1-mediated production of angiocrine factors 9-11 . By contrast, after chronic injury inflicted by iterative hepatotoxin (carbon tetrachloride) injection and bile duct ligation, constitutive FGFR1 signalling in liver sinusoidal endothelial cells counterbalanced CXCR7-dependent pro-regenerative response and augmented CXCR4 expression. This predominance of CXCR4 over CXCR7 expression shifted angiocrine response of liver sinusoidal endothelial cells, stimulating proliferation of desmin 1 hepatic stellate-like cells 22,23 and enforcing a pro-fibrotic vascular niche. Endothelial-cell-specific ablation of either Fgfr1 (Fgfr1 iDEC/iDEC ) or Cxcr4 (Cxcr4 iDEC/iDEC ) in mice restored the pro-regenerative pathway and prevented FGFR1-mediated maladaptive subversion of angiocrine factors. Similarly, selective CXCR7 activation in liver sinusoidal endothelial cells abrogated fibrogenesis. Thus, we demonstrate that in response to liver injury, differential recruitment of proregenerative CXCR7-Id1 versus pro-fibrotic FGFR1-CXCR4 angiocrine pathways in vascular niche balances regeneration and fibrosis. These results provide a therapeutic roadmap to achieve hepatic regeneration without provoking fibrosis 1, 2, 4 .
As such, defining the multicellular crosstalk that balances regeneration and dysfunctional (maladaptive) healing 5 holds promise for designing treatment for liver diseases.
LSECs that line liver sinusoidal vasculature induce hepatic organogenesis in manners that extend beyond their passive role for metabolite delivery 9, 12, 14, 15 . By deploying paracrine growth regulators, which we have defined as angiocrine factors, LSECs trigger regeneration of hepatocytes [9] [10] [11] 25, 26 . However, aberrant activation of LSECs in the context of chronic injury provokes fibrosis 16, 17 . This dichotomy of LSEC niche function in mediating liver repair implies divergent angiocrine signals balance regeneration and fibrosis 11 . Therefore, we sought to decipher the mechanisms that subvert pro-regenerative capacity of LSECs to a pro-fibrotic state.
In response to tissue injury, cytokines and chemokines, such as stromalderived factor (SDF)-1 (Cxcl12), are upregulated to initiate regeneration by switching on its receptors CXCR4 and CXCR7 (refs 18-21) . Although CXCR4 activation both in haematopoietic and in vascular cells modulates angiogenesis and haematopoiesis, expression of another SDF-1 receptor, CXCR7, is mainly restricted to endothelial cells, with its function primarily believed to be pivotal in vascular patterning and tumour neo-angiogenesis. However, elucidating the mechanism by which the SDF-1 pathway orchestrates liver repair is hindered by the lack of cell-type-specific genetic models in defined settings of liver injuries.
To unravel the divergent role of LSECs in modulating liver repair, we used a single injection of carbon tetrachloride (CCl 4 ) and acetaminophen, which cause acute liver injury, as well as chronic injury models of repeated CCl 4 injection and bile duct ligation (BDL) ( Fig. 1a ). At day 2 after single CCl 4 injury, CXCR7 was upregulated specifically in vascular endothelial (VE)-cadherin 1 LSECs (Fig. 1b-e and Supplementary Fig. 1 ). By contrast, CXCR4 is broadly expressed by other cell types, and its expression remains relatively stable on LSECs after CCl 4 injury. Therefore, we have identified CXCR7 as an inducible LSEC-specific SDF-1 receptor in response to liver injury.
Our group 9,10 and others 13 have shown that after partial hepatectomy LSECs, by producing angiocrine factors such as Wnt2 and hepatocyte growth factor (HGF), elicit liver regeneration. Activation of transcription factor Id1 in LSECs was essential for this process 9 . SDF-1 induced Id1 upregulation in cultured human LSECs, which was abrogated by genetic silencing of either Cxcr7 or Cxcr4 ( Fig. 1f and Supplementary  Figs 2 and 3 ). CXCR7-selective agonist TC14012 similarly induced Id1 upregulation. Immunoprecipitation-western blot demonstrated that after SDF-1 stimulation, CXCR7 was associated with CXCR4 and b-arrestin in LSECs ( Supplementary Fig. 4 ). Therefore, SDF-1 stimulates Id1 induction through enabling cooperation between CXCR7 and CXCR4 (refs 27 and 28) .
To determine the contribution of CXCR7 in LSEC-mediated liver repair, we used a tamoxifen-inducible endothelial-cell-specific Cre ERT2 system to knockdown Cxcr7 in the endothelial cells of adult mice (Fig. 1g ). Mice harbouring loxP site-flanking Cxcr7 were crossed with VE-Cad-Cre ERT2 /Cdh5-PAC-Cre ERT2 mice whereby endothelial-cell-specific VE-cadherin promoter drives Cre ERT2 . Mice carrying tdTomato fluorescent protein following the floxed stop codon were used to exclude off-target effects of VE-Cad-Cre ERT2 on other liver cell types. Tamoxifen injection specifically activated Cre ERT2 activity in endothelial cells but not desmin-expressing stellate-like cells ( Fig. 1h and Supplementary  Fig. 5 ), demonstrating induced endothelial-cell-specific deletion of Cxcr7 (Cxcr7 iDEC/iDEC ) in VE-cad-Cre ERT2 Cxcr7 loxP/loxP mice. Cxcr7haplodeficient adult mice (Cxcr7 iDEC/1 ) were used as control for Cre toxicity.
Compared with control mice, hepatocyte proliferation in Cxcr7 iDEC/iDEC mice was significantly decreased after CCl 4 injury ( Fig. 1i, j) . Id1dependent deployment of angiocrine factors HGF and Wnt2 from LSECs of Cxcr7 iDEC/iDEC mice was reduced both after CCl 4 -and after acetaminophen-induced liver injuries (Fig. 1k ). The extent of liver injury, as determined by the concentration of serum alanine aminotransferase, was exacerbated ( Fig. 1l and Supplementary Fig. 6 ). Thus, after liver injury, SDF-1 through activation of CXCR7 1 LSECs triggers an angiocrine response to initiate liver regeneration ( Fig. 1m ).
Although hepatocytes regenerate after acute liver injury, chronic liver damage more frequently leads to activation of myofibroblasts and causes fibrosis 2,3,5 . To address how the pro-regenerative angiocrine signals of LSECs are diverted to provoke this maladaptive healing, we used a mouse model of chronic liver injury by repeated CCl 4 injection 29 ( Fig. 2a, b ). The CXCR7-Id1 pathway in LSECs was counterbalanced by CXCR4 upregulation after chronic injury ( Fig. 2c -e and Supplementary Figs 7 and 8). After repeated CCl 4 injection, protein concentrations of a-smooth muscle actin (SMA) and extracellular matrix protein collagen were augmented in Cxcr7 iDEC/iDEC mice, compared with control mice (Fig. 2f-h and Supplementary Figs 9 and 10 ). Injection of CXCR7-specific agonist TC14012 reduced the upregulation of SMA and collagen I in control but not Cxcr7 iDEC/iDEC mice (Fig. 2g, h in LSECs stimulates angiocrine-mediated regeneration. a, Liver injury models for studying the maladaptive transition of pro-regenerative LSEC function to a pro-fibrotic vascular niche. b-e, CXCR7 is specifically upregulated on VE-cadherin 1 CD31 1 LSECs after acute chemical injury. After injection of CCl 4 , CXCR7 and CXCR4 were determined in isolated LSECs (b), liver sections (c, d) and non-parenchymal cells (NPCs) (e). CXCR7 was expressed on LSECs but not large vessels; n 5 5. Scale bar, 50 mm in Fig. 1 ; all data hereafter are presented as mean 6 s.e.m. f, SDF-1 stimulation of human LSECs upregulates inhibitor of DNA binding 1 (Id1) protein, a transcription factor inducing production of pro-regenerative angiocrine factors 9 . Id1 stimulation by SDF-1 in primary human Factor VIII 1 LSECs was abrogated by silencing of Cxcr4 and Cxcr7 in LSECs; n 5 5. g, h, Endothelial cell (EC)-specific inducible deletion of Cxcr7(Cxcr7 iDEC/iDEC ) in mice. Mice harbouring loxP sites flanking Cxcr7 were crossed with a mouse line with endothelial-cell-specific VE-cadherin promoter-driven Cre ERT2 (VE-Cad-Cre ERT2 /Cdh5-PAC-Cre ERT2 ).
Specificity of VE-Cad-Cre ERT2 /Cdh5-PAC-Cre ERT2 was validated in reporter mice carrying tdTomato protein following floxed stop codon. Cxcr7 deletion or tdTomato expression in endothelial cells was induced by tamoxifen injection 9 .
Cxcr7 iDEC/1 mice served as control. Note the specific expression of tdTomato in endothelial cells but not desmin 1 stellate-like cells (h, white arrows). i-l, Impaired liver regeneration and enhanced liver injury in Cxcr7 iDEC/iDEC mice after acute liver injury. Cell proliferation was determined by staining for bromodeoxyuridine(BrdU) incorporation (i, j). Expression of Id1 and pro-regenerative angiocrine factors, HGF and Wnt2, in LSECs was measured after CCl 4 and acetaminophen administration (k) and serum alanine aminotransferase (ALT) concentration was assessed to determine the degree of liver injury (l); n 5 4. m, CXCR7 activation in LSECs triggers Id1-mediated production of pro-regenerative angiocrine factors. After acute liver injury, CXCR7 cooperates with CXCR4, inducing pro-regenerative Id1 pathway in LSECs and triggering angiocrine-mediated liver regeneration. Perivascular green cells denote stellate-like cells (refs 1-3, 22, 23). Supplementary Fig. 11 ). Therefore, chronic liver injury interferes with pro-regenerative CXCR7-Id1 angiocrine pathway in LSECs and promotes fibrosis. The requirement of CXCR7 in LSECs in resolving liver fibrosis was tested 6, 23 . After three CCl 4 injections, SMA and collagen protein concentrations were enhanced in control mice; they peaked at day 8 after last injection and approached basal (vehicle-injected group) amount at day 20 ( Fig. 2i-j and Supplementary Figs 12 and 13) . By contrast, timedependent resolution of liver injury was impaired in Cxcr7 iDEC/iDEC mice. Id1 pathway inhibition by repeated injection of CCl 4 was prevented by CXCR7 agonist TC14012 (Fig. 2k ). Therefore, in response to injury, the CXCR7 pathway in LSECs plays an indispensible role in stimulating regeneration and resolving fibrosis. After iterative stimuli, predominance of the CXCR4 pathway over the CXCR7-Id1 pathway in LSECs leads to fibrosis (Fig. 2l ).
We then used BDL, a clinically relevant liver cholestasis model, to define how CXCR4 and CXCR7 modulate pro-fibrotic transition of LSECs (Fig. 3a) . BDL induces biliary epithelial injury and causes continuous cholestasis and cirrhosis. After BDL, LSECs were invested by perisinusoidal desmin 1 stellate-like cells (Fig. 3b ). Similar to repeated CCl 4 injuries, there was temporal upregulation of CXCR4 and suppression of CXCR7-Id1 pathways in LSECs (Fig. 3c ). SMA deposition in the liver of Cxcr7 iDEC/iDEC mice was higher than that of control Cxcr7 iDEC/1 mice ( Fig. 3d-f ). As such, loss of CXCR7 signalling in LSECs leads to fibrosis during BDL-induced cholestatic injury.
Human LSECs were then stimulated with angiogenic factors VEGF-A and FGF-2 to investigate the mechanism whereby CXCR4 expression is enhanced to dominate over the CXCR7 pathway. FGF-2, but not VEGF-A, increased CXCR4 messenger RNA (mRNA) and protein concentrations, and attenuated CXCR7 expression ( Fig. 3g and Supplementary Fig. 14) . Specific inhibition of mitogen-activated protein kinase (MAPK) blocked FGF-2-driven CXCR4 induction and CXCR7 inhibition in LSECs 11 (Fig. 3h ). As a result, treatment of human LSECs by FGF-2 suppressed Id1 induction by SDF-1 (Fig. 3i , j and Supplementary Fig. 15 ), suggesting that FGF-2-induced CXCR4 upregulation and CXCR7 suppression in LSECs negate the Id1 pro-regenerative pathway.
To test how FGF-2 signalling modulates angiocrine response of LSECs, we examined the activation of the FGF-2 receptor FGFR1 on LSECs after BDL. There was a time-dependent upregulation and activation of FGFR1 (refs 16, 29, 30) concomitant with phosphorylation of MAPK (Erk1/2) in the injured VE-cadherin 1 LSECs (Fig. 3k . Sirius red staining was used to detect collagen in the injured liver. Scale bar, 50 mm in Fig. 2 . c-e, Chronic liver injury suppresses CXCR7 pathway and upregulates CXCR4 expression in LSECs. Quantitative PCR (c), immunostaining (d) and flow cytometry (e) showed the abrogation of CXCR7-Id1 pathway in VE-cadherin (VE-Cad) 1 LSECs after chronic CCl 4 injury. CXCR4 is expressed in both endothelial cells and non-endothelial cells (white arrow). *P , 0.05 versus vehicle-treated mice; n 5 5. f-h, CXCR7 activation in LSECs negates liver fibrosis. The extent of fibrosis was augmented in Cxcr7 iDEC/iDEC mice, as evidenced by elevated hepatic amounts of a-SMA and collagen I (g, sirius red staining). CXCR7-selective agonist TC14012 reduced fibrosis in control but not Cxcr7 iDEC/iDEC mice. i, j, Impaired resolution of liver injury in Cxcr7 iDEC/iDEC mice. The amount of SMA in the injured liver was tested to assess the resolution of injury (i). Compared with control mice, the amount of SMA in Cxcr7 iDEC/iDEC mice was enhanced after last CCl 4 injection and remained stable afterwards. The amount of collagen I was similarly assessed ( Supplementary  Fig. 13 ); *P , 0.05, **P , 0.01, versus control mice; n 5 4. k, CXCR7 activation restores Id1 induction in chronically injured LSECs. TC14012 prevented Id1 suppression in LSECs during repeated CCl 4 injury. *P , 0.05, **P , 0.01, compared with vehicle group; n 5 5. l, Interference with pro-regenerative CXCR7-Id1 pathway in LSECs causes pro-fibrotic transition of vascular niche. After injury, upregulation of the CXCR7-Id1 pathway in LSECs induces generation of hepaticactive angiocrine factors and stimulates regeneration. Chronic injury perturbs CXCR7-Id1 signalling, counteracting regeneration and provoking fibrogenesis.
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FGFR1-mediated MAPK activation in LSECs, resulting in CXCR4dominated pro-fibrotic transition of angiocrine response during liver repair (Fig. 3m) .
To elucidate the mechanism underlying the pro-fibrotic drift of LSEC niche, we conditionally ablated Fgfr1 and Cxcr4 in endothelial cells of adult mice (Fgfr1 iDEC/iDEC and Cxcr4 iDEC/iDEC ) (Fig. 4a ). After BDL, perisinusoidal expansion of desmin 1 cells, deposition of collagen and SMA, MAPK activation and CXCR7 suppression in LSECs of Fgfr1 iDEC/iDEC mice were all prevented compared with control mice (Fig. 4b-g and Supplementary Fig. 18 ). CXCR7-dependent angiocrine expression of Wnt2 and HGF was restored in Fgfr1 iDEC/iDEC mice (Fig. 4e) . Therefore, endothelial-cell-specific deletion of Fgfr1 in adult mice prevented the aberrant transition of LSECs into a pro-fibrotic state by BDL.
To unravel the altered angiocrine response in chronically injured LSECs, we isolated and analysed LSECs from BDL and sham-operated mice ( Supplementary Fig. 19 ). In injured LSECs, there was significant upregulation of pro-fibrotic factors, including transforming growth factor (TGF)-b, bone morphogenetic protein (BMP)2 and plateletderived growth factor (PDGF)-C, concomitant with suppression of anti-fibrotic genes, such as follistatin and apelin. This divergent drift of angiocrine factor production in LSECs after BDL was diminished in Fgfr1 iDEC/iDEC mice, as evidenced by restoration of anti-fibrotic genes and reduced expression of fibrotic factors (Fig. 4h ).
The extent of fibrosis after BDL was further tested in Cxcr4 iDEC/iDEC mice. Compared with control Cxcr4 iDEC/1 mice, hepatic deposition of SMA and collagen, and perisinusoidal accumulation of desmin 1 stellate-like cells, were reduced in Cxcr4 iDEC/iDEC mice after BDL (Fig. 4i-m and Supplementary Fig. 20 ). The reduction of liver fibrosis in Cxcr4 iDEC/iDEC mice implies that constitutive CXCR4 activation in LSECs by chronic injury establishes a pro-fibrotic vascular niche, activating adjacent myofibroblast cells and provoking fibrogenesis (Fig. 4n) .
Although liver regeneration after partial hepatectomy proceeds impeccably without fibrosis, liver repair after chronic injury is associated with fibrosis that compromises restoration of liver function. Therefore, identifying the molecular pathways modulating liver regeneration and aberrant healing will open up therapeutic avenues for treatment of liver cirrhosis and failure. We have shown that after 70% partial hepatectomy, activation of the VEGFR2-Id1 pathway in LSECs leads to liver regeneration 9 . Here we demonstrate that FGFR1-mediated CXCR4 upregulation and CXCR7 suppression in LSECs counterbalance the pro-regenerative function of LSECs and lead to fibrosis.
We used complementary acute and chronic injury models to decipher the contribution of LSECs in liver repair (Fig. 1a ). In the mouse liver, we have identified a preferential induction of pro-regenerative CXCR7dependent signalling in LSECs that responds to acute injury (Fig. 1) . 
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During chronic liver injury, loss of CXCR7 and upregulation of CXCR4 in LSECs causes progression to fibrosis. Indeed, the critical function of CXCR7 activation in promoting regeneration and counteracting fibrosis is evidenced by the attenuated fibrosis by selective activation of CXCR7 in LSECs, as well as by impaired regeneration (Fig. 1 ) and enhanced fibrogenesis (Figs 2 and 3) in Cxcr7 iDEC/iDEC mice. The shift in SDF-1 signalling from the CXCR7-dependent proregenerative response to a CXCR4-dominated pro-fibrotic function in LSECs is due to persistent FGFR1 that drives chronic MAPK activation 11, 16, 29, 30 (Fig. 3) . We used an inducible endothelial-cell-specific mouse genetic deletion system to demonstrate the contribution of FGFR1-CXCR4 pathway in the pro-fibrotic drift of LSECs. After chronic liver injury, the enhanced CXCR4 expression relative to CXCR7 in LSECs was prevented in Fgfr1 iDEC/iDEC mice, and both Fgfr1 iDEC/iDEC and Cxcr4 iDEC/iDEC mice were resistant to fibrosis (Fig. 4) . Therefore, activation of CXCR7-Id1 in LSECs upon injury triggers and safeguards production of hepatogenic angiocrine factors, whereas persistent FGFR1-CXCR4 activation by chronic stimuli converts LSECs to a pro-fibrotic niche. This aberrant angiocrine response of LSECs by the FGFR1-CXCR4 pathway causes activation and expansion of desmin 1 stellatelike cells. Elucidating how hepatic stellate cells reciprocally modulate phenotypic and functional contributions of LSECs in liver repair remains to be investigated 1, 23 . Moreover, whether activation of CXCR7 and CXCR4 on LSECs regulates inflammatory responses, such as recruitment of macrophages that could potentially modulate liver regeneration and fibrosis 6, 8 , needs to be studied.
In summary, we have found that differentially activated LSECs supply divergent angiocrine signals for liver repair. Selective activation of CXCR7 in LSECs is instrumental in shepherding angiocrine-mediated regeneration. Perturbation of the CXCR7 pathway by constitutive FGFR1 Liver NPCs (BDL day 10) Fig. 19 ). This pro-fibrotic drift of angiocrine factor in LSECs after BDL was mitigated in Fgfr1 iDEC/iDEC mice; n 5 4. i-m, Reduction of liver fibrosis in Cxcr4 iDEC/iDEC mice after BDL. The extent of liver fibrosis after BDL was significantly lower in Cxcr4 iDEC/iDEC mice than that of control mice, as evidenced by decreased deposition of collagen (i, j, sirius red staining), SMA protein (k, l), and perisinusoidal enrichment of desmin 1 stellate-like cells (m, white arrow); n 5 5. n, Divergent angiocrine signals from LSECs balance liver regeneration and fibrosis. After acute liver injury, activation of CXCR7-Id1 pathway in LSECs stimulates production of hepatic-active angiocrine factors. By contrast, chronic injury causes persistent FGFR1 activation in LSECs that perturbs CXCR7-Id1 pathway and favours a CXCR4-driven pro-fibrotic angiocrine response, thereby provoking liver fibrosis. Therefore, in response to injury, differentially primed LSECs deploy divergent angiocrine signals to balance liver regeneration and fibrosis.
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activation diverts SDF-1 signalling in LSECs to a CXCR4-dominated maladaptive (pro-fibrotic) angiocrine response. Taken together, we demonstrate that endothelial cells are not just inert cellophane conduits delivering metabolites but also establish a vascular niche that instructively dictates regeneration and healing. Identifying molecular pathways orchestrating divergent angiocrine responses in the hepatic vascular niche will lay the foundation for therapeutic strategy that ensures liver repair without causing fibrosis.
METHODS SUMMARY
Generation of endothelial-cell-specific inducible gene deletion was performed by treating VE-Cad-Cre ERT2 /Cdh5-PAC-Cre ERT2 -harbouring mice with tamoxifen 10 . Mice carrying loxP sites flanking Cxcr7 were provided by ChemoCentryx (generated by L. Gan (University of Rochester)). Floxed Cxcr4 mice were offered by Y.-R. Zou (the Feinstein Institute for Medical Research, Manhasset, New York). Sex-, age-and weight-matched littermate animals with indicated genotypes were used and compared in all experimental groups. All animal experiments were performed under the guidelines set by the Institutional Animal Care and Use Committee at Weill Cornell Medical College. Single and repeated injections of CCl 4 were used to induce acute and chronic liver injuries, respectively 29 . To perform BDL, the common bile duct was ligated and severed by incision between ligation. Livers were collected for the analysis of fibrogenesis, including collagen deposition by Sirius red staining, and desmin protein by immunoblot (Abcam). TC14012 (R&D) was injected intraperitoneally into the mice after CCl 4 injury every other day at 30 mg kg 21 . LSECs were isolated from mice as previously described 9 . Human LSECs were obtained from ScienCell TM Research Laboratories. Tissues were collected and cryopreserved as previously described 9, 10 . Antibodies characterizing liver vasculature and fibroblasts were incubated with cryosections 9 . Flow cytometry analysis of LSECs was performed on liver non-parenchymal cells 9 . The sample size (n) of each experimental group is described in each corresponding figure legend, and all experiments were repeated at least three times. Statistical analysis used two-way analysis of variance. All data are presented as mean 6 s.e.m.
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